Skip to main content
Earnings Labs
Immatics N.V. logo

Immatics N.V. (IMTX)

NASDAQ·Healthcare·Biotechnology

$6.35

-0.22%

Mkt Cap $1.03B

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (7 analysts)

$17.00

Range $17.00 – $17.00

Implied Upside

+167.9%

Consensus $17.00 vs current $6.35